(Q40505199)

21 September 2017

Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models (English)

1 reference

21 September 2017

0 references

5

Donald F Smee

1 reference

21 September 2017

1

John D Morrey

1 reference

21 September 2017

Craig W Day

2

1 reference

21 September 2017

Justin G Julander

series ordinal

3

1 reference

21 September 2017

Lawrence M Blatt

series ordinal

4

1 reference

21 September 2017

Robert W Sidwell

series ordinal

6

1 reference

21 September 2017

1 March 2004

1 reference

Antiviral Chemistry & Chemotherapy

21 September 2017

1 reference

21 September 2017

15

1 reference

21 September 2017

101-109

1 reference

21 September 2017

2

1 reference

Human immunoglobulin as a treatment for West Nile virus infection

21 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Efficacy of Interferon -2b and Ribavirin Against West Nile Virus In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Clinical characteristics of the West Nile fever outbreak, Israel, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Death from the Nile crosses the Atlantic: the West Nile Fever story

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Interferons, Interferon Inducers, and Interferon-Ribavirin in Treatment of Flavivirus-Induced Encephalitis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Current treatment strategies for chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Immunomodulation as a treatment strategy for genital herpes: review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Identification of active antiviral compounds against a New York isolate of West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

West Nile virus: a primer for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A x A.By)F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Postinfection therapy of arbovirus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

A review of the applications of imiquimod: a novel immune response modifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Protection Against Japanese Encephalitis Virus in Mice and Hamsters by Treatment with Carboxymethylacridanone, a Potent Interferon Inducer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus): A Model for West Nile Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020401500202

10.1177/095632020401500202

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference